An Age of Exciting New Medicine That Many Cannot Afford

Andrew L. Pecora, MD
Published: Monday, Oct 12, 2015
Andrew L. Pecora, MD

Andrew L. Pecora, MD

Editor-in-Chief of Oncology Business Management

Chief Innovations Officer, Professor, and Vice President of Cancer Services

John Theurer Cancer Center at Hackensack University Medical Center

President, Regional Cancer Care Associates, LLC

As the holiday season rolls in, one can imagine the conversation around the family table when a loved one expresses grief that they have a serious-to-life-threatening medical problem. Adding to the shock, they tell you that the illness can be effectively addressed with some new drug or procedure but because of their new high deductible and 20% co-pay insurance plan, the care is not affordable.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication